New cholesterol-buster from Esperion now available in U.S.
ANN ARBOR—Esperion Therapeutics Inc. has finally launched the cholesterol busting drug the company has been development and made Nexlizet tablets available in the United States. Nexlizet is a combination of bempedoic acid and ezetimibe. Bempedoic acid is the Esperion-developed active ingredient in Nexletol tablets, approved by the U.S. Food and Drug Administration and introduced earlier





